McCray Edwin, Waguia Romaric, de la Garza Ramos Rafael, Price Meghan J, Williamson Theresa, Dalton Tara, Sciubba Daniel M, Yassari Reza, Goodwin Andrea N, Fecci Peter, Johnson Margaret O, Chaichana Kaisorn, Goodwin C Rory
Department of Neurosurgery, Spine Division, Duke University Medical Center, Durham, North Carolina, USA.
Department of Neurosurgery, Montefiore Medical Center/Albert Einstein College of Medicine, New York City, New York, USA.
Neurooncol Pract. 2022 Jul 31;10(1):62-70. doi: 10.1093/nop/npac061. eCollection 2023 Feb.
Few studies have assessed the impact of race on short-term patient outcomes in the brain metastasis population. The goal of this study is to evaluate the association of race with inpatient clinical presentation, treatment, in-hospital complications, and in-hospital mortality rates for patients with brain metastases (BM).
Using data collected from the National Inpatient Sample between 2004 and 2014, we retrospectively identified adult patients with a primary diagnosis of BM. Outcomes included nonroutine discharge, prolonged length of stay (pLOS), in-hospital complications, and mortality.
Minority (Black, Hispanic/other) patients were less likely to receive surgical intervention compared to White patients (odds ratio [OR] 0.70; 95% confidence interval [CI] 0.66-0.74, < 0.001; OR 0.88; 95% CI 0.84-0.93, < 0.001). Black patients were more likely to develop an in-hospital complication than White patients (OR 1.35, 95% CI 1.28-1.41, < 0.001). Additionally, minority patients were more likely to experience pLOS than White patients (OR 1.48; 95% CI 1.41-1.57, < 0.001; OR 1.34; 95% CI 1.27-1.42, < 0.001). Black patients were more likely to experience a nonroutine discharge (OR 1.25; 95% CI 1.19-1.31, < 0.001) and higher in-hospital mortality than White (OR 1.13; 95% CI 1.03-1.23, = 0.008).
Our analysis demonstrated that race is associated with disparate short-term outcomes in patients with BM. More efforts are needed to address these disparities, provide equitable care, and allow for similar outcomes regardless of care.
很少有研究评估种族对脑转移患者短期预后的影响。本研究的目的是评估种族与脑转移(BM)患者的住院临床表现、治疗、院内并发症及院内死亡率之间的关联。
利用2004年至2014年从国家住院患者样本中收集的数据,我们回顾性地确定了原发性诊断为BM的成年患者。结局包括非常规出院、住院时间延长(pLOS)、院内并发症及死亡率。
与白人患者相比,少数族裔(黑人、西班牙裔/其他)患者接受手术干预的可能性较小(比值比[OR]0.70;95%置信区间[CI]0.66 - 0.74,<0.001;OR 0.88;95% CI 0.84 - 0.93,<0.001)。黑人患者比白人患者更易发生院内并发症(OR 1.35,95% CI 1.28 - 1.41,<0.001)。此外,少数族裔患者比白人患者更易出现住院时间延长(OR 1.48;95% CI 1.41 - 1.57,<0.001;OR 1.34;95% CI 1.27 - 1.42,<0.001)。黑人患者比白人患者更易出现非常规出院(OR 1.25;95% CI 1.19 - 1.31,<0.001),且院内死亡率更高(OR 1.13;95% CI 1.03 - 1.23,=0.008)。
我们的分析表明,种族与BM患者不同的短期结局相关。需要做出更多努力来解决这些差异,提供公平的护理,并使无论接受何种护理都能获得相似的结局。